These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2566063)

  • 1. Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
    Lancet; 1989 May; 1(8647):1130-1. PubMed ID: 2566063
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
    De Wit S; Weerts D; Goossens H; Clumeck N
    Lancet; 1989 Apr; 1(8641):746-8. PubMed ID: 2564563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fluconazole in the treatment of esophageal, bronchial and oral candidiasis in patients with ARC and AIDS].
    Gritti FM; Raise E; Di Salvo S; Vannini V; Lanzoni G; Cucci AM
    G Ital Chemioter; 1988; 35(1-3):61-8. PubMed ID: 2855730
    [No Abstract]   [Full Text] [Related]  

  • 4. Itraconazole and fluconazole in oropharyngeal candidiasis.
    van der Bijl P; Arendorf TM
    Ann Dent; 1993; 52(2):12-6. PubMed ID: 8267372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
    Hernández-Sampelayo T
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):340-4. PubMed ID: 8070443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study.
    Leen CL; Dunbar EM; Ellis ME; Mandal BK
    J Infect; 1990 Jul; 21(1):55-60. PubMed ID: 2200826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
    Hegener P; Troke PF; Fätkenheuer G; Diehl V; Ruhnke M
    AIDS; 1998 Nov; 12(16):2227-8. PubMed ID: 9833866
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of itraconazole and ketoconazole in HIV-positive patients with oropharyngeal or esophageal candidiasis. Human Immunodeficiency Virus Itraconazole Ketoconazole Project Group.
    de Repentigny L; Ratelle J
    Chemotherapy; 1996; 42(5):374-83. PubMed ID: 8874977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole resistant candida in AIDS.
    Fox R; Neal KR; Leen CL; Ellis ME; Mandal BK
    J Infect; 1991 Mar; 22(2):201-4. PubMed ID: 2026897
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluconazole resistance in AIDS patients.
    Willocks L; Leen CL; Brettle RP; Urquhart D; Russell TB; Milne LJ
    J Antimicrob Chemother; 1991 Dec; 28(6):937-9. PubMed ID: 1816193
    [No Abstract]   [Full Text] [Related]  

  • 12. Oropharyngeal candidiasis: a new treatment option.
    Klotz SA
    Clin Infect Dis; 2006 Apr; 42(8):1187-8. PubMed ID: 16575740
    [No Abstract]   [Full Text] [Related]  

  • 13. Gentian violet, ketoconazole and nystatin in oropharyngeal and esophageal candidiasis in Zairian AIDS patients.
    Nyst MJ; Perriens JH; Kimputu L; Lumbila M; Nelson AM; Piot P
    Ann Soc Belg Med Trop; 1992 Mar; 72(1):45-52. PubMed ID: 1567268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida albicans resistance in AIDS.
    Kitchen VS; Savage M; Harris JR
    J Infect; 1991 Mar; 22(2):204-5. PubMed ID: 2026898
    [No Abstract]   [Full Text] [Related]  

  • 15. New triazole antifungal agents (fluconazole and itraconazole) in the treatment of HIV-related gastrointestinal candidiasis.
    Nathwani D; Green ST; McGuire W; Goldberg DJ; Kennedy DH
    Scand J Infect Dis; 1989; 21(3):355-6. PubMed ID: 2547244
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients.
    Dupont B; Drouhet E
    J Med Vet Mycol; 1988 Feb; 26(1):67-71. PubMed ID: 2837559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study.
    Chave JP; Cajot A; Bille J; Glauser MP
    J Infect Dis; 1989 Apr; 159(4):806-7. PubMed ID: 2538523
    [No Abstract]   [Full Text] [Related]  

  • 18. Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
    Horn CA; Washburn RG; Givner LB; Peacock JE; Pegram PS
    AIDS; 1995 May; 9(5):533-4. PubMed ID: 7639986
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluconazole for ketoconazole-resistant oropharyngeal candidiasis in HIV-1 infected patients.
    Thorsen S; Mathiesen LR
    Scand J Infect Dis; 1990; 22(3):375-6. PubMed ID: 2371551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis].
    Corzo Delgado JE; Lozano de León F; Aretio Najarro R; Martín Mazuelos E
    Med Clin (Barc); 1994 Nov; 103(16):639. PubMed ID: 7996928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.